Background and Purpose Chemotherapy-induced cachexia (CIC) causes severe
metabolic abnormalities independently of cancer and reduces the
therapeutic efficacy of chemotherapy. The underlying mechanism of CIC
remains unclear. Here we investigated the cytarabine (CYT)-induced
alteration in energy balance and its underlying mechanisms in mice.
Experimental Approach We compared energy balance-associated parameters
among the three groups of mice: CON, CYT, and PF (pair-fed mice with the
CYT group) that were intravenously administered vehicle or CYT. Key
Results Weight gain, fat mass, skeletal muscle mass, grip strength, and
nocturnal energy expenditure were significantly lowered in the CYT group
than in the CON and PF groups. The CYT group demonstrated less energy
intake than the CON group and higher respiratory quotient than the PF
group, indicating that CYT induced cachexia independently from the
anorexia-induced weight loss. Serum triglyceride and fecal lipid levels
were significantly lower, whereas the intestinal mucosal triglyceride
levels and the lipid content within the small intestine enterocyte were
higher after lipid loading in the CYT group than in the CON and PF
groups, suggesting that CYT inhibited lipid uptake in the intestine.
This was not associated with obvious intestinal damage. The CYT group
showed increased zipper-like junctions of lymphatic endothelial vessel
in duodenal villi compared to that in the CON and CYT groups, suggesting
their imperative role in the CYT-induced inhibition of lipid uptake.
Conclusion and Implications CYT worsens cachexia independently of
anorexia by inhibiting the intestinal lipid uptake, presumably via the
increased zipper-like junctions of lymphatic endothelial vessel.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.